LifeMD Names COO and Promotes Two Executives
LifeMD (NASDAQ: LFMD), a virtual healthcare services provider, has announced key leadership appointments. Shayna Webb Dray, previously Senior VP of Operations, has been promoted to Chief Operating Officer. Webb Dray, who joined LifeMD in 2021, brings over 15 years of operations and supply chain experience.
The company also expanded Jessica Friedeman's role to Chief Marketing and Product Officer and promoted Jacob Ellison to Chief Analytics Officer, where he will lead data strategy and AI innovation. These appointments aim to strengthen LifeMD's operational excellence and support its expansion into new healthcare verticals.
LifeMD (NASDAQ: LFMD), un fornitore di servizi sanitari virtuali, ha annunciato importanti nomine dirigenziali. Shayna Webb Dray, precedentemente Senior VP delle Operazioni, è stata promossa a Chief Operating Officer. Webb Dray, che è entrata in LifeMD nel 2021, vanta oltre 15 anni di esperienza in operazioni e gestione della catena di approvvigionamento.
L'azienda ha inoltre ampliato il ruolo di Jessica Friedeman a Chief Marketing and Product Officer e promosso Jacob Ellison a Chief Analytics Officer, incaricato di guidare la strategia dei dati e l'innovazione nell'IA. Queste nomine mirano a rafforzare l'eccellenza operativa di LifeMD e a supportare la sua espansione in nuovi settori sanitari.
LifeMD (NASDAQ: LFMD), un proveedor de servicios de salud virtual, ha anunciado nombramientos clave en su liderazgo. Shayna Webb Dray, anteriormente Vicepresidenta Senior de Operaciones, ha sido promovida a Directora de Operaciones. Webb Dray, que se unió a LifeMD en 2021, aporta más de 15 años de experiencia en operaciones y cadena de suministro.
La compañía también amplió el rol de Jessica Friedeman a Directora de Marketing y Producto y promovió a Jacob Ellison a Director de Análisis, donde liderará la estrategia de datos y la innovación en IA. Estos nombramientos buscan fortalecer la excelencia operativa de LifeMD y apoyar su expansión en nuevos sectores de salud.
LifeMD (NASDAQ: LFMD)는 가상 헬스케어 서비스 제공업체로서 주요 리더십 임명을 발표했습니다. 이전에 운영 부문 수석 부사장이었던 Shayna Webb Dray가 최고운영책임자(COO)로 승진했습니다. 2021년에 LifeMD에 합류한 Webb Dray는 15년 이상의 운영 및 공급망 경험을 보유하고 있습니다.
회사는 또한 Jessica Friedeman의 역할을 최고 마케팅 및 제품 책임자로 확대하고, Jacob Ellison을 최고 분석 책임자로 승진시켜 데이터 전략과 AI 혁신을 이끌도록 했습니다. 이번 임명은 LifeMD의 운영 우수성을 강화하고 새로운 헬스케어 분야로의 확장을 지원하기 위한 것입니다.
LifeMD (NASDAQ : LFMD), un fournisseur de services de santé virtuelle, a annoncé des nominations clés à sa direction. Shayna Webb Dray, auparavant vice-présidente senior des opérations, a été promue directrice des opérations. Webb Dray, qui a rejoint LifeMD en 2021, possède plus de 15 ans d'expérience dans les opérations et la chaîne d'approvisionnement.
L'entreprise a également étendu le rôle de Jessica Friedeman en tant que directrice marketing et produit, et promu Jacob Ellison au poste de directeur de l'analytique, où il dirigera la stratégie des données et l'innovation en intelligence artificielle. Ces nominations visent à renforcer l'excellence opérationnelle de LifeMD et à soutenir son expansion dans de nouveaux secteurs de la santé.
LifeMD (NASDAQ: LFMD), ein Anbieter von virtuellen Gesundheitsdienstleistungen, hat wichtige Führungspositionen besetzt. Shayna Webb Dray, zuvor Senior VP Operations, wurde zur Chief Operating Officer befördert. Webb Dray, die 2021 zu LifeMD kam, bringt über 15 Jahre Erfahrung in den Bereichen Betrieb und Lieferkette mit.
Das Unternehmen hat außerdem die Rolle von Jessica Friedeman zur Chief Marketing and Product Officer erweitert und Jacob Ellison zum Chief Analytics Officer befördert, der künftig die Datenstrategie und KI-Innovationen leiten wird. Diese Ernennungen sollen die operative Exzellenz von LifeMD stärken und die Expansion in neue Gesundheitsbereiche unterstützen.
- Internal promotion of experienced executive Shayna Webb Dray to COO position
- Strategic expansion of leadership team with focus on product development and analytics
- Demonstrated success in launching and scaling weight management program
- None.
NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual healthcare services, today announced the appointment of Shayna Webb Dray as its Chief Operating Officer. Ms. Webb Dray, an accomplished operations and supply chain executive with over 15 years of experience, has been an integral part of LifeMD’s growth, most recently serving as Senior Vice President of Operations.
“Shayna's proven track record of building and managing an industry-leading operations team and infrastructure in a complex and rapidly growing environment makes her the ideal leader to step into the role of COO,” said Justin Schreiber, Chairman and Chief Executive Officer of LifeMD. “I am confident Shayna will play a pivotal role in supporting LifeMD’s growth into new verticals, and ensuring that the quality of care we provide and the overall patient experience is second to none in the industry.”
Ms. Webb Dray joined LifeMD in 2021 as the Head of Supply Chain and Procurement, where she spearheaded the creation of a comprehensive supply chain strategy. In 2023, she was named Senior Vice President of Operations and was responsible for the successful launch, operationalization and scaling of the company’s weight management program. She also oversees the strategic direction of the Care Center, Pharmacy, Clinical Operations and Project Management Office. Prior to joining LifeMD, she served as Executive Director of Operations at Kaplan Publishing, a Graham Holdings subsidiary. She holds a Bachelor of Science in Supply Chain Management and Marketing from Syracuse University, where she was a Brethen Scholar.
“It has been incredibly gratifying to be a part of the dynamic and collaborative team leading LifeMD’s tremendous growth,” said Ms. Webb Dray. “I look forward to continue delivering meaningful patient experiences alongside operational excellence, and transforming the future of healthcare.”
In addition, LifeMD has expanded Chief Marketing Officer Jessica Friedeman’s role to include oversight of Product as the Chief Marketing and Product Officer. Jacob Ellison, LifeMD’s Vice President of Analytics, has been appointed Chief Analytics Officer, where he will oversee the organization’s data strategy, AI innovation and FP&A.
“We are incredibly fortunate to have strong internal talent to drive enhancements across LifeMD,” added Mr. Schreiber. “Jessica’s dedication to delivering high quality, innovative products to patients makes her uniquely positioned to lead our product organization.” He continued, “Jacob’s insight into not just what the data says, but the impact it has on our business and our patients allows him to consistently drive value throughout the organization.”
About LifeMD, Inc.
LifeMD® is a leading provider of virtual primary care. LifeMD offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across more than 200 conditions, including primary care, men’s and women's health, weight management, and hormone therapy. The Company leverages a vertically integrated, proprietary digital care platform, a 50-state affiliated medical group, a state-of-the-art affiliated pharmacy, and a U.S.-based patient care center to increase access to high-quality and affordable care. For more information, please visit LifeMD.com.
Cautionary Note Regarding Forward Looking Statements
This news release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended; Section 21E of the Securities Exchange Act of 1934, as amended; and the safe harbor provision of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in this news release may be identified by the use of words such as: “believe,” “expect,” “anticipate,” “project,” “should,” “plan,” “will,” “may,” “intend,” “estimate,” “predict,” “continue,” and “potential,” or, in each case, their negative or other variations or comparable terminology referencing future periods. Examples of forward-looking statements include, but are not limited to, statements regarding our financial outlook and guidance, short and long-term business performance and operations, future revenues and earnings, regulatory developments, legal events or outcomes, ability to comply with complex and evolving regulations, market conditions and trends, new or expanded products and offerings, growth strategies, underlying assumptions, and the effects of any of the foregoing on our future results of operations or financial condition.
Forward-looking statements are not historical facts and are not assurances of future performance. Rather, these statements are based on our current expectations, beliefs, and assumptions regarding future plans and strategies, projections, anticipated and unanticipated events and trends, the economy, and other future conditions, including the impact of any of the aforementioned on our future business. As forward-looking statements relate to the future, they are subject to inherent risk, uncertainties, and changes in circumstances and assumptions that are difficult to predict, including some of which are out of our control. Consequently, our actual results, performance, and financial condition may differ materially from those indicated in the forward-looking statements. These risks and uncertainties include, but are not limited to, “Risk Factors” identified in our filings with the Securities and Exchange Commission, including, but not limited to, our most recently filed Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and any amendments thereto. Even if our actual results, performance, or financial condition are consistent with forward-looking statements contained in such filings, they may not be indicative of our actual results, performance, or financial condition in subsequent periods.
Any forward-looking statement made in the news release is based on information currently available to us as of the date on which this release is made. We undertake no obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise, except as may be required under applicable law or regulation.
Investor Contact
Marc Benathen, Chief Financial Officer
marc@lifemd.com
Media Contact
Jessica Friedeman, Chief Marketing and Product Officer
press@lifemd.com
FAQ
Who is the new COO of LifeMD (NASDAQ: LFMD)?
What is Shayna Webb Dray's experience before joining LifeMD?
What other executive changes did LifeMD announce in July 2025?
What are Shayna Webb Dray's achievements at LifeMD?
